These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 32540271)

  • 1. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Schaefer GO; Tam CC; Savulescu J; Voo TC
    Vaccine; 2020 Jul; 38(33):5085-5088. PubMed ID: 32540271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulation of COVID-19 "Challenge" Studies.
    Menikoff J
    Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768
    [No Abstract]   [Full Text] [Related]  

  • 3. So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
    Grady C; Shah S; Miller F; Danis M; Nicolini M; Ochoa J; Taylor H; Wendler D; Rid A
    Vaccine; 2020 Sep; 38(41):6381-6387. PubMed ID: 32826103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical guidelines for deliberately infecting volunteers with COVID-19.
    Richards AD
    J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
    Eyal N
    Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    Wang EA; Zenilman J; Brinkley-Rubinstein L
    JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
    [No Abstract]   [Full Text] [Related]  

  • 8. Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.
    Evans NG
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible treatment of Covid-19 with a therapeutic vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Apr; 186(13):419. PubMed ID: 32245869
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 11. Audio Interview: Covid-19 Vaccine Development.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccine development pipeline gears up.
    Mullard A
    Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine development, access, and equity.
    Kim JH
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 33064151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
    Shih HI; Wu CJ; Tu YF; Chi CY
    Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
    Baay M; Neels P
    Biologicals; 2020 Sep; 67():69-74. PubMed ID: 32829985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings.
    ;
    BMC Med; 2020 Oct; 18(1):342. PubMed ID: 33115460
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).
    Calina D; Docea AO; Petrakis D; Egorov AM; Ishmukhametov AA; Gabibov AG; Shtilman MI; Kostoff R; Carvalho F; Vinceti M; Spandidos DA; Tsatsakis A
    Int J Mol Med; 2020 Jul; 46(1):3-16. PubMed ID: 32377694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.